Evaluation, Improvement, and Impact; part of the CTSA Administration core; applies principles of continuous quality improvement and evidence-based decision-making throughout and across CTSA functions. Evaluation, Improvement, and Impact aims to advance CTSA opportunities for organizational learning and understanding of impact. We focus on the Duke hub but also contribute to CTSA nationally, including participation in the CLIC-CTSA Program Evaluators Group.

Leadership

Jessica Sperling

Jessica Sperling, PhD

Director; Evaluation, Improvement, and Impact
Joseph McClernon, PhD

F. Joseph McClernon, PhD

Associate Director, Duke Clinical and Translational Science Institute
Stella Quenstedt

Stella Quenstedt, MA

Research Analyst; Evaluation, Improvement, and Impact
Perusi Benson

Perusi Muhigaba, PhD

Project Manager and Research Analyst; Evaluation, Improvement, and Impact

Major Activities

  • Consultation and advising on evaluation and evaluation-related methods - request a consultation

  • Case studies of research projects developed and/or supported by CTSA

  • CTSA Metrics Tracker (CMT) platform development and pilot implementation

  • Ongoing Core metrics determination and collection

  • Contribution to specific CTSA-aligned projects and initiative (e.g., The Duke Endowment “Research at Pickett (R@P) Road”)

  • Contribution to CTSA-wide efforts (e.g., Exec. Advisory Committee contribution, 4.0 planning)

Upcoming Events